Amneal Pharmaceuticals Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 13.83, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the second quarter 2026. Average receivable collection period, for the Amneal Pharmaceuticals Inc in Jun 30 2026 quarter, has decreased to 26 days, compared to 27 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 78 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 855, from overall ranking in the first quarter 2026 at 1047.

What is Receivable Turnover Ratio?
What is Amneal Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AMRX Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	215.7 %	4.31 %	15.39 %	-84.94 %	-99.87 %
Y / Y Revenue Change	9.93 %	3.92 %	11.59 %	11.75 %	3.2 %
Receivable Turnover Ratio (TTM)	13.83	13.56	13.44	15.06	14.5
AMRX's Total Ranking	# 855	# 1047	# 832	# 864	# 2592
Accounts Receivable average collection period days	26	27	27	24	25
Seq. Receivable Change	889.37 %	-99.94 %	69183.51 %	-18.84 %	226.9 %
Seq. Revenue Change	10.26 %	-11.42 %	3.98 %	8.25 %	4.23 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 31
Healthcare Sector	# 79
Overall Market	# 855

Receivable Turnover Ratio Statistics
High	Average	Low
16.18	6.04	2.5
(Mar 31 2024)		(Dec 31 2019)

AMRX Company Profile • Back to AMRX Efficiency Comparisons • Compare AMRX Receivables Turnover Ratio to its Competitors

Financial Statements
Amneal Pharmaceuticals Inc 's Accounts Receivable	$ 5 Millions	Visit AMRX's Balance sheet
Amneal Pharmaceuticals Inc 's Sales TTM	$ 3,117 Millions	Visit AMRX's Income Statement
Sources of AMRX's Revenues		Visit AMRX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AMRX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AMRX's Growth Rates	AMRX's Roa	AMRX's Inventory Turnover Ratio	AMRX's Dividend Comparisons
AMRX's Profitability Ratios	AMRX's Roi	AMRX's Asset Turnover Ratio	AMRX's Dividend Growth
AMRX's Valuation Ratios	AMRX's Roe	AMRX's Financial Strength Ratios	AMRX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Logicmark Inc	1,686.71	$ 12.544 Millions	$ 0.007 Millions
Orchestra Biomed Holdings Inc	453.56	$ 31.976 Millions	$ 0.071 Millions
Nakamoto Inc	386.16	$ 28.962 Millions	$ 0.075 Millions
Immunocore Holdings Plc	195.08	$ 430.775 Millions	$ 2.208 Millions
Agape Atp Corporation	190.27	$ 1.152 Millions	$ 0.006 Millions
Hcw Biologics Inc	175.24	$ 6.843 Millions	$ 0.039 Millions

Date modified: 2026-09-05T14:54:35+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.